# TrueHealth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/truehealth

- Industry: Medical Devices & Equipment
- Headquarters: Zhuhai, China
- Website: www.truehealth.cn
- Total disclosed funding: $25M
- Latest round: Series B (Jul 30, 2024)
- Investors on record: 4

## About

Founded in 2018 and based in Zhuhai, China, Guangdong True Health Medical Technology Development Co., Ltd., trading as TrueHealth, is a medical device company that focuses on the development and manufacture of medical surgical robots. The company was awarded the Medical Device Quality Management System Certificate in 2021 and the Specialized Small and Medium-sized Enterprise (SME) Certificate in 2022. In June 2026, it raised nearly CNY 449.87 million in an IPO, selling 3564700 shares at CNY 126.2 per share on the Hong Kong Exchanges And Clearing Limited, under the ticker "2697".

The company's main business is the development and manufacture of medical surgical robots. Its self-developed products include an image analysis and puncture planning system, an optical navigation system, a respiratory tracking system, and a multi-axis robotic arm positioning system.

TrueHealth generates revenue from the sales of medical devices and related medical services.

The company will use the proceeds from the IPO to support its research and development activities and commercialization of its products, fulfil its working capital and other
general corporate purposes.

## Funding rounds

- Series B, Jul 30, 2024, $11M — Tppoly Capital, Hengqin IDC
- Series B, Nov 22, 2023, $14M — China International Capital Corporation, Science and Technology Creating Investment

## Investors

- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B
- Science and Technology Creating Investment (https://capitalatlas.ai/funds/science-and-technology-creating-investment) — Series B
- Tppoly Capital (https://capitalatlas.ai/funds/tppoly-capital) — Series B
- Hengqin IDC — Series B